Nexo Therapeutics is a biopharmaceutical company focused on drug discovery for elusive drug targets in various disease areas. The company aims to address challenges in drug development by finding quality ligands for targets and understanding the pharmacology required to effectively modulate these targets.

Nexo Therapeutics

Nexo Therapeutics is a small molecule oncology company dedicated to the discovery and development of new drugs for cancer patients who currently lack meaningful therapies. Nexo combines covalent ligand discovery and chemical biology with expertise in cancer biology and medicinal chemistry to target fundamental drivers of cancer by innovative approaches. With facilities in Golden, CO and Watertown, MA, Nexo is led by Founder and CEO, Andrew Phillips, PhD. For more information, please visit www.nexotx.com.

Nexo Therapeutics has received reports of employment scams that purport to extend job offers or seek financial commitments from job candidates. Unsuspecting job seekers have reported receiving unsolicited contacts by phone, email or text from individual(s) claiming to be or represent Nexo recruiter(s). Be advised that Nexo is not recruiting any for data entry roles and does not extend unsolicited employment offers. Furthermore, Nexo does not charge prospective employees any fees or a security deposit nor do we ask for any bank account information during the recruitment process . If a person claims to provide recruitment services for Nexo for a fee to the applicant or offers an unsolicited job offer, please be advised that the person is not affiliated in any way with Nexo.

If you are interested in an employment opportunity with Nexo Therapeutics, please visit our official page on LinkedIn for any listings. All active searches will be listed and any job postings that do not link to this page are not legitimate and might be fraudulent.

You may report any such behavior via info@nexotx.com. If you have been defrauded or suspect identity theft as a result of an employment scam, please contact your local law enforcement agency for guidance.

news_impact_assignment_basic

key_people

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

merger_acquisitions

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general
public peers	general	Aug 25, 2024 8:41 AM	6081965b
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general
company summary	general
signals	general
crunchbase trigger	general
crunchbase profile	general
li profile	general	Aug 25, 2024 8:41 AM	c30caf43
translate crunchbase fundingrounds	general
peers	general	Aug 25, 2024 8:41 AM	9b0e78df
news basic	general	Aug 25, 2024 8:41 AM	5ea18a4b
bundesanzeiger	filings
merger acquisitions	company_analysis
financials download nd	financials
private financials	financials

NEXO

COM:NEXOTX

Nexo Therapeutics